Get started
Live feed
SECFilingvia Quantisnow
AstraZeneca PLC logo

AZN: SEC Form 6-K filed by AstraZeneca PLC

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for AZN

Across the 19 sessions after earlier AZN headlines, the stock closed higher 9 times and lower 10 times, with a median move of 1.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

AZN close-to-close change in the session after earlier headlines
SessionEarlier headlineAZNSPY
Oct 30, 2026Enhertu® Wins 2026 International Prix Galien Award for Best Biotechnology Productand 1 other headline that session+7.0%-1.8%
Oct 28, 2026AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing-0.3%+0.3%
Oct 27, 2026Enhertu® Approved in the EU as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer-1.2%+0.6%
Oct 26, 2026Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01and 3 other headlines that session+0.3%+0.7%
Oct 22, 2026ZEGFROVY® (sunvozertinib) now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations+2.4%-1.2%
Oct 20, 2026TEZSPIRE positive results from Phase III CROSSING trial in eosinophilic esophagitis including symptom improvement, histologic and endoscopic remission presented at United European Gastroenterology Week+3.0%+0.3%
Quantisnow market dataNYSE
AstraZeneca PLC logo
AZN
AstraZeneca PLC
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2026
Get push alerts for AZN

Follow AZN and get a push notification the moment its next story breaks.

Full AZN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AZN (AstraZeneca PLC) and more on Quantisnow.